Implications of microRNA-197 downregulated expression in esophageal cancer with poor prognosis

Genetics and Molecular Research

Volumn 13, Issue 3, 2014, Pages 5574-5581

  Wang, T Y ^a   Liu, S G ^b   Zhao, B S ^b   Qi, B ^b   Qin, X G ^b   Yao, W J ^b  

^a XINXIANG MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

Esophageal cancer; MicroRNA 197; Prognosis

Indexed keywords

MICRORNA; MICRORNA 197; UNCLASSIFIED DRUG; MIRN197 MICRORNA, HUMAN;

ADULT; AGED; ARTICLE; ASSAY; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DOWN REGULATION; ESOPHAGUS CANCER; FEMALE; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MALE; MICRORNA ASSAY; MIDDLE AGED; RNA EXTRACTION; SURVIVAL TIME; TUMOR RECURRENCE; TUMOR VOLUME; CANCER GRADING; ESOPHAGUS TUMOR; GENE EXPRESSION; GENETICS; METASTASIS; MORTALITY; PATHOLOGY; PROGNOSIS;

ADULT; AGED; DOWN-REGULATION; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; TUMOR BURDEN;

EID: 84905013495     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2014.July.25.12     Document Type: Article

References (25)

1. Ambros V (2004). The functions of animal microRNAs. Nature 431: 350-355.
2. Bagga S, Bracht J, Hunter S, Massirer K, et al. (2005). Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell 122: 553-563.
3. Du L, Schageman JJ, Subauste MC, Saber B, et al. (2009). miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1. Mol. Cancer Res. 7: 1234-1243.
4. Filipowicz W, Bhattacharyya SN and Sonenberg N (2008). Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat. Rev. Genet. 9: 102-114.
5. Guo Y, Chen Z, Zhang L, Zhou F, et al. (2008). Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res. 68: 26-33.
6. Hamada S, Satoh K, Miura S, Hirota M, et al. (2013). miR-197 induces epithelial-mesenchymal transition in pancreatic cancer cells by targeting p120 catenin. J. Cell Physiol. 228: 1255-1263.
7. He B, Pan Y, Cho WC, Xu Y, et al. (2012). The association between four genetic variants in microRNAs (rs11614913, rs2910164, rs3746444, rs2292832) and cancer risk: evidence from published studies. PLoS One 7: e49032.
8. Hobert O (2008). Gene regulation by transcription factors and microRNAs. Science 319: 1785-1786.
9. Kim VN (2005). MicroRNA biogenesis: coordinated cropping and dicing. Nat. Rev. Mol. Cell Biol. 6: 376-385.
10. Lee RC, Feinbaum RL and Ambros V (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75: 843-854.
11. Liang M (2009). MicroRNA: a new entrance to the broad paradigm of systems molecular medicine. Physiol. Genomics 38: 113-115.
12. Liang M, Liu Y, Mladinov D, Cowley AW, Jr., et al. (2009). MicroRNA: a new frontier in kidney and blood pressure research. Am. J. Physiol. Renal Physiol. 297: F553-F558.
13. Lim LP, Lau NC, Garrett-Engele P, Grimson A, et al. (2005). Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433: 769-773.
14. Lin RJ, Xiao DW, Liao LD, Chen T, et al. (2012). MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma. J. Surg. Oncol. 105: 175-182.
15. Mathé EA, Nguyen GH, Bowman ED, Zhao Y, et al. (2009). MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin. Cancer Res. 15: 6192-6200.
16. Meister G (2007). miRNAs get an early start on translational silencing. Cell 131: 25-28.
17. Scapoli L, Palmieri A, Lo ML, Pezzetti F, et al. (2010). MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression. Int. J. Immunopathol. Pharmacol. 23: 1229-1234.
18. Sobin LH, Gospodarowicz MK and Wittekind C (2002). TNM Classification of Malignant Tumours (UICC International Union Against Cancer). Wiley-Blackwell Publish House, New York.
19. Xu X, Chen Z, Zhao X, Wang J, et al. (2012). MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma. Biochem. Biophys. Res. Commun. 421: 640-645.
20. Yang C, Wang C, Chen X, Chen S, et al. (2013a). Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas. Int. J. Cancer 132: 116-127.
21. Yang M, Liu R, Sheng J, Liao J, et al. (2013b). Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of esophageal squamous cell carcinoma. Oncol. Rep. 29: 169-176.
22. Yu Z, Baserga R, Chen L, Wang C, et al. (2010). microRNA, cell cycle, and human breast cancer. Am. J. Pathol. 176: 1058-1064.
23. Zheng D, Haddadin S, Wang Y, Gu LQ, et al. (2011). Plasma microRNAs as novel biomarkers for early detection of lung cancer. Int. J. Clin. Exp. Pathol. 4: 575-586.
24. Zhou ZQ, Cao WH, Xie JJ, Lin J, et al. (2009). Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma. BMC Cancer 9: 291.
25. Zoon CK, Starker EQ, Wilson AM, Emmert-Buck MR, et al. (2009). Current molecular diagnostics of breast cancer and the potential incorporation of microRNA. Expert. Rev. Mol. Diagn. 9: 455-467.